Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 10INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Neoplasms 2Cancer Pain 2Vomiting 1Pain 1

Interventions

pembrolizumab 1023Carboplatin 964Paclitaxel 933Gemcitabine 794Cisplatin 751Docetaxel 683Bevacizumab 609Pemetrexed 502Nivolumab 487Cyclophosphamide 471Capecitabine 461Fluorouracil 418Dexamethasone 403Rituximab 372Oxaliplatin 348Injections 345atezolizumab 298Trastuzumab 298Leucovorin 288Cetuximab 282Irinotecan 268130-nm albumin-bound paclitaxel 254Prednisone 245Doxorubicin 240Ipilimumab 226Lenalidomide 220fludarabine 218Fulvestrant 217durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Dronabinol × Clear all
NCT06533657 2026-04-21

UTOPIA-1

ZYUS Life Sciences Inc.

Phase 2 Completed
11 enrolled

Cancer Pain

NCT00674609 2023-05-03

SPRAY

Jazz Pharmaceuticals

Phase 3 Completed
177 enrolled 21 charts

Neoplasms, Pain

NCT05272865 2023-02-01

Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC

LaSanta S A S

Phase 1/2 Unknown
334 enrolled

Cancer Pain, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡